FINALS: HISTOPATHOLOGY Flashcards

(44 cards)

1
Q

IMMUNOHISTOCHEMISTRY
- X ___, special procedure in ___
- involves ___

A
  • routine
  • disease diagnosis
  • antigen-antibody reactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PURPOSE OF IHC:

A
  • Most common form of Ab used in IHC
  • For identification of tissue / cellular antigens / phenotypic markers
  • Detection of organisms (microbes: cause diseases) in cytologic procedures (sputum, body fluids, FNA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ANTIGENS (found in ___)

A
  • cells
  • to be detected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ANTIBODIES (class of ___, ___)
Most common Ig used?

A
  • serum proteins
  • immunoglobulins
  • IgG
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TYPES OF ANTIBODIES USED IN IHC
A. ___
- produced by ___
- react w/ ___
- from ___
Main Source:
Other Source:

A
  • POLYCLONAL
  • different cells
  • various isotopes
  • laboratory animal sources
  • RABBITS - immunized to produce Abs
  • GOATS, PIGS, SHEEP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TYPES OF ANTIBODIES USED IN IHC
B. ___
- more ___
- produced from ___
- reacts only w/ ___
Main Animal Source:

A

B. MONOCLONAL
- specific
- individual clone of plasma cell
- 1 specific type of isotope
- MICE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LABELLING OF ANTIBODIES
1. USE OF ___
Most widely used?
Alternative?

A
  • ENZYMES
  • HRP (HORSE RADISH PEROXIDASE)
  • AP (ALKALINE PHOSPHATASE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Required in use of enzymes to see ___?

Required by chromogens; ___?

A
  • CHROMOGENS -> color developers
  • positive result
  • SUBSTRATE
  • consumed by enzyme
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ab + ___ to react w/ antigen

A

E + C + S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Enzyme: HRP (HORSE RADISH PEROXIDASE)
Substrate: ___

Chromogen:
1. ___
Color:
Suitable Counterstains:

  1. ___
    Color:
    Suitable Counterstains:
A

Enzyme: HRP (HORSE RADISH PEROXIDASE)
Substrate: HYDROGEN PEROXIDASE (H2O2)

Chromogen:
1. DAB (3,3’ DAB diaminobenzidine)
Color: Brown
Suitable Counterstains: Hematoxylin, Methyl green, Methyl blue

  1. AEC (3-amino-9-ethylcarbazole)
    Color: Brick red
    Suitable Counterstains: Hematoxylin, Methyl blue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Enzyme: AP (ALKALINE PHOSPHATASE)
Substrate: ___

Chromogen:
1. ___
Color:
Suitable Counterstains:

  1. ___
    Color:
    Suitable Counterstains:
A

Enzyme: AP (ALKALINE PHOSPHATASE)
Substrate: Phosphate

Chromogen:
1. BCIP (5-Bromo-4-Chloro-3-Indolyl Phosphate) / NBT (Nitro Blue Tetrazolium)
Color: Bluish violet / Black violet
Suitable Counterstains: Nuclear fast red, Brilliant green

  1. FAST TR RED SALT
    Color: Rose color
    Suitable Counterstains: NONE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Used to observe end products?
Fluorochrome dye used?

A
  • LIGHT MICROSCOPE
  • FLUORESCENCE MICROSCOPE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HEMATOXYLIN AS COUNTERSTAIN
- ___; ___

MAYER’S OR HARRIS HEMATOXYLIN - ___
MAYER’S - ___
HARRIS - ___; ___

A
  • traditional counterstain; nuclear stain
  • Immunohistochemistry
  • Reddish violet
  • Red; commonly used bc tissue morphology are well-defined
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

INCUBATION - ___
Incubation time & temperature to link Ab w/ ___

A
  • required to link Ag to Ab
  • 30-60 MINS AT ROOM TEMPERATURE
  • peroxidase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LABELLING OF ANTIBODIES:
2. USE OF ___
- requires ___
Most common:

A
  • FLUROCHROME LABEL
  • FLUORESCENCE MICROSCOPE
  • FITC (FLUORESCENCE ISOTHIOCYANATE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LABELLING OF ANTIBODIES:
3. USE OF ___
GOLD - ___ end-product (under ____

A
  • COLLOIDAL METALS
  • pink
  • light microscope
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

LABELLING OF ANTIBODIES:
4. ___

To detect ___ (traditionally use ___)
- Can bind w/ ___; can also be ___
Source:

A
  • RADIO LABEL
  • LECTINS
  • antigen
  • antibody
  • tissue carbohydrates
  • labeled
  • PLANT / ANIMALS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SPECIMENS FOR IHC:
1. ___
- for ___
- done ___ (while ___)
- tissue prepared as ___ & must be fixed for a few sections using ___ / ___
Preparation: Cut tissue using ___ / ___

A
  • FROZEN SECTION
  • rapid diagnosis
  • intraoperatively
  • patient is in OR
  • cryostat section
  • METHANOL / ACETONE
  • freezer microtome / CRYOSTAT
19
Q

PURPOSE OF FIXATION:

A
  1. To preserve the position of antigens being detected
  2. To prevent destruction of labile antigenic sites
20
Q

SPECIMENS FOR IHC:
2. ___ LIKE ___ & ___

Preferred fixative for IHC?

Required for processed specimens?
Purpose:

A
  • PROCESSED SPECIMENS
  • Formalin fixed, Paraffin embedded
  • FORMALDEHYDE
  • ANTIGEN RETRIEVAL
  • Increase accessibility of Ag to Ab
21
Q

2 GENERAL METHODS OF ANTIGEN RETRIEVAL:
1. ___

  1. ___ / ___
    MOST COMMON ENZYMES USED:
    Both can break ___
    Forms crosslinks?
A
  • HIER (HEAT INDUCED EPITOPE RETRIEVAL)
  • PIER (PROTEASED INDUCED EPITOPE RETRIEVAL) / PROTEOLYTIC ENZYME RETRIEVAL
  • TRYPSIN, PROTEASE
  • formalin crosslinks
  • 10% FORMALIN AS FIXATIVE
22
Q

PRE-TREATMENT
BLOCKING - only for ___, X ___
1. ___
- ___
- uses ___

  1. ___
    - all ___ & reduces ___
    - uses ___
A
  • processed specimen
  • frozen section
  • PEROXIDASE BLOCK
  • endogenous peroxidases
  • 3% H2O2 (HYDROGEN PEROXIDE)
  • PROTEIN BLOCK
  • non-specific sites
  • background
  • 10% NORMAL SERUM
23
Q

PURPOSE OF USE OF CONTROL AS REQUIREMENT IN IHC:

A
  1. To test for specificity of Abs involved
  2. To prevent misinterpretation due to false + & false - results
24
Q

POSITIVE CONTROL - tissue section having the ___

NEGATIVE CONTROL - omit ___ from ___ / replace ___ by an __ directed against an ___

INTERNAL TISSUE CONTROL / BUILT IN CONTROL -contains ___ not only in the ___ but also in ___

A
  • Ag being detected
  • primary Ab
  • staining sched
  • primary Ab
  • Ig
  • unrelated Ig
  • target Ag
  • tissue elements
  • adjacent normal tissue elements
25
DETECTION USING LABELED ENZYME ANTIBODY 1. ___ - use of ___ - Add ___ 2. ___ - ___ of traditional (direct); ___ of direct - involves addition of ___; more ___ 3. ___ - ___ - requires use of ___ PRIMARY Ab - SECONDARY Ab - will attach / bind to ___ -> ___ (better ___)
- DIRECT - only 1 Ab that is labeled - labeled Ab to Ag being detected - EPOS (ENHANCED POLYMER ONE-STEP STAINING METHOD) - improvement - type - DEXTRAN POLYMER - sensitive - INDIRECT - two-step - 2 Abs - specific to Ag being detected - Fc portion of primary Ab - INCREASING SENSITIVITY - signal amplification
26
ENZYMATIC METHOD - ___ are labeled w/ ___ before ___; after reacting w/ ___, ___ is formed ___ - catalyzes ___ to yield a ___ w/c can be analyzed using either ___ / ___
- Abs - enzyme - reaction - targeted Ag - Ag-Ab COMPLEX - Ag-Ab COMPLEX - substrate - colored product - LM / EM
27
ADVANTAGES OF ENZYMATIC METHOD:
1. Standard samples can be stored for a long time 2. Hematoxylin can be used as a counterstain 3. End product can easily be identified using LM / EM 4. Will not require fluorescence microscope
28
AUTOMATION IN IHC:
1. Greater consistency of staining 2. Faster & more accurate 3. Less manpower 4. Decreased use of reagent
29
TUMOR MARKERS - for ___ & ___ of cancers - found in ___; markers for ___
- detection & staging - tissues - malignancies
30
A. EPITHELIAL TUMOR MARKERS 1. KERATIN - for ___; ___ CARCINOMA - ___ in origin SARCOMA - __ in origin Ex: CK 7 (CYTOKERATIN 7) - ___ CK 20 - ___ X all types of carcinoma will be ___ 2. EMA (EPITHELIAL MEMBRANE ANTIGEN) - ___ - determine ___; ___ 3. CEA (CARCINOEMBRYONIC ANTIGEN) - ___ - differentiates ___ from ___ ADENOCARCINOMA - cancer of ___ involving ___ - elevated: ___ - monitor ___ 4. TTF-I (THYROID TRANSCRIPTION FACTOR I) - differentiates ___ from ___ - found in ___ 5. PSA (PROSTATE SPECIFIC ANTIGEN) - highly specific for ___ - elevated: ___ 6. ER/PR (ESTROGEN-PROGESTERONE RECEPTOR) - normally found in ___ but X in ___ - prognosis & treatment: ___ - identification: ___
A. EPITHELIAL TUMOR MARKERS 1. KERATIN - for ___; ___ CARCINOMA - ___ in origin SARCOMA - __ in origin Ex: CK 7 (CYTOKERATIN 7) - ___ CK 20 - ___ X all types of carcinoma will be ___ 2. EMA (EPITHELIAL MEMBRANE ANTIGEN) - ___ - determine ___; ___ 3. CEA (CARCINOEMBRYONIC ANTIGEN) - ___ - differentiates ___ from ___ ADENOCARCINOMA - cancer of ___ involving ___ - elevated: ___ - monitor ___ 4. TTF-I (THYROID TRANSCRIPTION FACTOR I) - differentiates ___ from ___ - found in ___ 5. PSA (PROSTATE SPECIFIC ANTIGEN) - highly specific for ___ - elevated: ___ 6. ER/PR (ESTROGEN-PROGESTERONE RECEPTOR) - normally found in ___ but X in ___ - prognosis & treatment: ___ - identification: ___
31
A. EPITHELIAL TUMOR MARKERS 1. KERATIN - for ___; ___ CARCINOMA - ___ in origin SARCOMA - __ in origin Ex: CK 7 (CYTOKERATIN 7) - ___ CK 20 - ___ X all types of carcinoma will be ___
A. EPITHELIAL TUMOR MARKERS 1. KERATIN - for epithelial tissue cells; CARCINOMA CARCINOMA - epithelial in origin SARCOMA - connective tissue in origin Ex: CK 7 (CYTOKERATIN 7) - CANCER OF LUNGS, UTERUS, OVARIES CK 20 - COLON & STOMACH CANCER X all types of carcinoma will be (+) for CK
32
A. EPITHELIAL TUMOR MARKERS 2. EMA (EPITHELIAL MEMBRANE ANTIGEN) - ___ - determine ___; ___
A. EPITHELIAL TUMOR MARKERS 2. EMA (EPITHELIAL MEMBRANE ANTIGEN) - ADENOCARCINOMA - determine site of tumor; BREAST, LUNG, KIDNEY CANCER
33
A. EPITHELIAL TUMOR MARKERS 3. CEA (CARCINOEMBRYONIC ANTIGEN) - ___ - differentiates ___ from ___ ADENOCARCINOMA - cancer of ___ involving ___ - elevated: ___ - monitor ___
A. EPITHELIAL TUMOR MARKERS 3. CEA (CARCINOEMBRYONIC ANTIGEN) - oncofetal - differentiates ADENOCARCINOMA from MESOTHELIOMA ADENOCARCINOMA - cancer of epithelial tissues involving glands - elevated: CERTAIN CANCERS OF GIT - monitor COLON, PANCREAS, CERVIX, BREAST CANCER
34
A. EPITHELIAL TUMOR MARKERS 4. TTF-I (THYROID TRANSCRIPTION FACTOR I) - differentiates ___ from ___ - found in ___
A. EPITHELIAL TUMOR MARKERS 4. TTF-I (THYROID TRANSCRIPTION FACTOR I) - differentiates LUNG ADENOCARCINOMA from MESOTHELIOMA - found in thyroid neoplasm
35
A. EPITHELIAL TUMOR MARKERS 5. PSA (PROSTATE SPECIFIC ANTIGEN) - highly specific for ___ - elevated: ___
A. EPITHELIAL TUMOR MARKERS 5. PSA (PROSTATE SPECIFIC ANTIGEN) - highly specific for prostate - elevated: PROSTATE CANCER, PANCREATIC CANCER, SALIVARY TUMORS; PROSTATE INFECTION
36
A. EPITHELIAL TUMOR MARKERS 6. ER/PR (ESTROGEN-PROGESTERONE RECEPTOR) - normally found in ___ but X in ___ - prognosis & treatment: ___ - identification: ___
A. EPITHELIAL TUMOR MARKERS 6. ER/PR (ESTROGEN-PROGESTERONE RECEPTOR) - normally found in breast epithelial cells but X in myoepithelial cells - prognosis & treatment: BREAST CANCER - identification: METASTATIC BREAST CARCINOMA
37
B. INTERMEDIATE FILAMENT MARKERS 1. ACTIN - tumors derived from ___
B. INTERMEDIATE FILAMENT MARKERS 1. ACTIN - tumors derived from SMOOTH, CARDIAC, SKELETAL MUSCLES
38
B. INTERMEDIATE FILAMENT MARKERS 2. VIMENTIN - present in ___ & their counterparts: ___
B. INTERMEDIATE FILAMENT MARKERS 2. VIMENTIN - present in normal mesenchymal cells & their counterparts: SARCOMA, MELANOMA, LEUKEMIA, SEMINOMA SCHWANNOMAS
39
B. INTERMEDIATE FILAMENT MARKERS 3. DESMIN - highly specific for ___
B. INTERMEDIATE FILAMENT MARKERS 3. DESMIN - highly specific for MYOGENIC TUMORS
40
B. INTERMEDIATE FILAMENT MARKERS 4. GFAP (GLIAL FIBRILLARY ACIDIC PROTEIN) - confirms diagnosis of ___
B. INTERMEDIATE FILAMENT MARKERS 4. GFAP (GLIAL FIBRILLARY ACIDIC PROTEIN) - confirms diagnosis of ASTROCYTOMA
41
OTHER MARKERS: 1. HCG (HUMAN CHORIONIC GONADOTROPIN) - ___
OTHER MARKERS: 1. HCG (HUMAN CHORIONIC GONADOTROPIN) - CHORIOCARCINOMA
42
OTHER MARKERS: 2. AFP (ALPHA FETOPROTEIN) - ___ TERATOMAS - usually ___, aka ___
OTHER MARKERS: 2. AFP (ALPHA FETOPROTEIN) - EMBRYONAL CARCINOMAS & TERATOMAS, HEPATOCELLULAR CARCINOMAS TERATOMAS - usually benign, aka MONSTROUS TUMORS
43
OTHER MARKERS: 3. LYMPHOMAS / CD 45 - best screening marker for ___
OTHER MARKERS: 3. LYMPHOMAS / CD 45 - best screening marker for LYMPHOMA
44
2 MOST COMMON MARKERS TO ASSESS PROLIFERATION OF TUMOR CELLS
1. Ki 2. MIB-I